Journal
JOURNAL OF CLINICAL PATHOLOGY
Volume 58, Issue 2, Pages 196-201Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/jcp.2004.018515
Keywords
-
Categories
Ask authors/readers for more resources
Background: Recent Dutch guidelines recommend adjuvant systemic treatment (AST) for women with high grade stage I breast carcinoma greater than or equal to1 cm. High grade is defined as Bloom and Richardson grade 3 (B&R3), Nottingham modification, or mitotic activity (MAI) greater than or equal to 10/1.59 mm(2). Aims: To investigate the validity of these histological prognostic factors as the exclusive defining criteria. Materials/methods: Fifty patients with stage I breast carcinoma who developed distant metastases and 50 matched controls without metastasis were studied; none had received AST. Results: Cases more often had tumours greater than or equal to1 cm (p = 0,019), B&R3 tumours (p = 0.059), grade 3 nuclei (p = 0.005), and vascular invasion (p = 0.007). No differences were found for MAI greater than or equal to 10 (p = 0.46). In multivariate analysis, the only significant variables were vascular invasion and tumour size ( odds ratios: 8.21 and 5.35, respectively). In a separate analysis, the 50 cases were divided into 25 patients with early and 25 with late metastasis. Those with early metastasis more often had B&R3 tumours (p = 0.009) and grade 3 nuclei (p = 0.006). No differences were found for tumours greater than or equal to 1 cm, vessel invasion, or MAI greater than or equal to 10. Using the present Dutch guidelines for AST, based on B&R3, 20 cases and 11 controls would have received AST. Based on MAI greater than or equal to 10, 14 cases and 11 controls would have received AST. Conclusions: Tumour size and vessel invasion are the best prognostic factors for disease free survival in patients with stage I breast cancer. Dutch selection criteria for AST for these patients need to be improved. Some prognostic factors are time dependent, making their use as selection criteria for AST more complicated.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available